
Please try another search
HLB Pep Co., Ltd., a bio-venture company, engages in the manufacture and sale of peptide biomaterials and drug raw materials in South Korea and internationally. It offers GMP, generic, custom, and catalog peptides, as well as offers other services. The company develops AGM-130, which is in Phase I for the treatment of triple negative breast cancer. In addition, its pre-clinical products include AGM-331 targeted for anti-cancer therapy; AGM-380 indicated for the treatment of viral infection; and AGM-290 indicated for the treatment of infections caused by multidrug resistant bacteria. In addition, it is involved in the development of AGM-212 indicated for the treatment of Type 2 Diabetes; AGM-217 indicated for the treatment of Type 2 diabetes and obesity; and AGM-260 indicated for the treatment of Ulcerative colitis. The company was formerly known as Anygen Co., Ltd. and changed its name to HLB Pep Co., Ltd. in April 2025. The company was founded in 2000 and is headquartered in Gwangju-si, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Jae Il Kim | - | - | CEO & Director |
Ji-Yong Park | 57 | 2017 | R&D Director & Director |
Kook Sang Hwang | - | 2025 | Executive Director |
Kyoung Jae Shim | - | 2025 | CEO & Director |
You Deok Kim | - | 2025 | Executive Director |
Tae Il Lee | - | 2025 | Director of Audit & Director |
Daniel Rhee | - | 2025 | Director |
Sung Yun Hwang | - | 2025 | Director |
Young Tae Jeon | - | 2025 | Director |
YuDeok Kim | - | 2023 | MD & Executive Director |
KyungNam Kim | - | 2024 | Director of Audit & Director |
Yeong Su Jeon | - | 2024 | Director of Audit & Director |
GukSang Hwang | - | 2023 | MD & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review